These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32803903)

  • 1. Open trial of Bruton's tyrosine kinase inhibitor (PRN1008) in the treatment of canine pemphigus foliaceus.
    Goodale EC; White SD; Bizikova P; Borjesson D; Murrell DF; Bisconte A; Francesco M; Hill RJ; Masjedizadeh M; Nunn P; Gourlay SG; Jordan TJM; Emery CB; Outerbridge CA
    Vet Dermatol; 2020 Oct; 31(5):410-e110. PubMed ID: 32803903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus.
    Goodale EC; Varjonen KE; Outerbridge CA; Bizikova P; Borjesson D; Murrell DF; Bisconte A; Francesco M; Hill RJ; Masjedizadeh M; Nunn P; Gourlay SG; White SD
    Vet Dermatol; 2020 Aug; 31(4):291-e71. PubMed ID: 31899567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and establishment of canine desmocollin-1 as a major autoantigen in canine pemphigus foliaceus.
    Bizikova P; Dean GA; Hashimoto T; Olivry T
    Vet Immunol Immunopathol; 2012 Oct; 149(3-4):197-207. PubMed ID: 22884397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers.
    Smith PF; Krishnarajah J; Nunn PA; Hill RJ; Karr D; Tam D; Masjedizadeh M; Funk JO; Gourlay SG
    Br J Clin Pharmacol; 2017 Nov; 83(11):2367-2376. PubMed ID: 28636208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trunk-dominant and classic facial pemphigus foliaceus in dogs - comparison of anti-desmocollin-1 and anti-desmoglein-1 autoantibodies and clinical presentations.
    Bizikova P; Linder KE; Mamo LB
    Vet Dermatol; 2022 Oct; 33(5):414-425. PubMed ID: 35670648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum autoantibody profiles of IgA, IgE and IgM in canine pemphigus foliaceus.
    Bizikova P; Olivry T; Mamo LB; Dunston SM
    Vet Dermatol; 2014 Oct; 25(5):471-e75. PubMed ID: 24975693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomapping of desmosomal and nondesmosomal adhesion molecules in healthy canine footpad, haired skin and buccal mucosal epithelia: comparison with canine pemphigus foliaceus serum immunoglobulin G staining patterns.
    Bizikova P; Linder KE; Olivry T
    Vet Dermatol; 2011 Apr; 22(2):132-42. PubMed ID: 20738839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Reversible Covalent Bruton's Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib).
    Owens TD; Brameld KA; Verner EJ; Ton T; Li X; Zhu J; Masjedizadeh MR; Bradshaw JM; Hill RJ; Tam D; Bisconte A; Kim EO; Francesco M; Xing Y; Shu J; Karr D; LaStant J; Finkle D; Loewenstein N; Haberstock-Debic H; Taylor MJ; Nunn P; Langrish CL; Goldstein DM
    J Med Chem; 2022 Apr; 65(7):5300-5316. PubMed ID: 35302767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoglein-1 is a minor autoantigen in dogs with pemphigus foliaceus.
    Olivry T; LaVoy A; Dunston SM; Brown RS; Lennon EM; Warren SJ; Prisayanh P; Müller EJ; Suter MM; Dean GA
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):245-55. PubMed ID: 16293316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluating the prevalence of anti-desmocollin-1 IgA autoantibodies in canine pemphigus foliaceus.
    Jordan TJM; Mamo LB; Olivry T; Liu Z; Bizikova P
    Vet Immunol Immunopathol; 2024 Jul; 273():110773. PubMed ID: 38820947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous polyautoimmunity in two unrelated dogs: pemphigus foliaceus and generalized discoid lupus erythematosus.
    Levy BJ; Linder KE; Mamo LB; Herrmann I; Bizikova P
    Vet Dermatol; 2020 Aug; 31(4):325-e84. PubMed ID: 32342582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine pemphigus foliaceus antigen is localized within desmosomes of keratinocyte.
    Yabuzoe A; Shimizu A; Nishifuji K; Momoi Y; Ishiko A; Iwasaki T
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):57-64. PubMed ID: 18976819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an enzyme-linked immunosorbent assay for detection of circulating IgG autoantibodies against canine desmoglein 3 in dogs with pemphigus.
    Nishifuji K; Tamura K; Konno H; Olivry T; Amagai M; Iwasaki T
    Vet Dermatol; 2009 Oct; 20(5-6):331-7. PubMed ID: 20178469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoperoxidase staining for the detection of autoantibodies in canine autoimmune skin disease; comparison to immunofluorescence results.
    Bradley GA; Mays MB
    Vet Immunol Immunopathol; 1990 Oct; 26(2):105-13. PubMed ID: 2260277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaflumizone-amitraz (Promeris)-associated pustular acantholytic dermatitis in 22 dogs: evidence suggests contact drug-triggered pemphigus foliaceus.
    Oberkirchner U; Linder KE; Dunston S; Bizikova P; Olivry T
    Vet Dermatol; 2011 Oct; 22(5):436-48. PubMed ID: 21418349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.
    Murrell DF; Patsatsi A; Stavropoulos P; Baum S; Zeeli T; Kern JS; Roussaki-Schulze AV; Sinclair R; Bassukas ID; Thomas D; Neale A; Arora P; Caux F; Werth VP; Gourlay SG; Joly P;
    Br J Dermatol; 2021 Oct; 185(4):745-755. PubMed ID: 33942286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus.
    Patsatsi A; Murrell DF
    Front Med (Lausanne); 2021; 8():708071. PubMed ID: 34447768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-of-the-art review of human autoimmune blistering diseases (AIBD).
    Zeng FAP; Murrell DF
    Vet Dermatol; 2021 Dec; 32(6):524-e145. PubMed ID: 34351020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.